Research location
Zhangzhou
Fujian, China
Advertisement
Research activity in Zhangzhou
Fujian, ChinaCureCurrent currently publishes aggregate city-level research activity for this location: 12 trials and 12 site observations.
The map is centered on registry-derived city coordinates. Circle size reflects published trial activity.
Below are current trials with one or more ClinicalTrials.gov site observations in this city. Results are paginated 50 per page, with recruiting studies shown first.
Trials with sites in Zhangzhou
12 linked trials · page 1 of 1Evaluation of the Inhaled TQC3721 Suspension in Patients With Moderate-to-Severe Chronic Obstructive Pulmonary DiseaseNCT07464587 · 2026-04-14 · 1 site observation
RECRUITING
A Study to Evaluate the Efficacy of Pumitamig Versus Pembrolizumab in Participants With Previously Untreated Advanced Non-Small Cell Lung Cancer and PD-L1 ≥ 50%. (ROSETTA Lung-202)NCT07361510 · 2026-03-12 · 1 site observation
RECRUITING
A Clinical Study of Neoadjuvant Treatment With TQB2102 for Injection for Human Epidermal Growth Factor Receptor 2 (HER2) Positive Breast CancerNCT07043725 · 2025-09-15 · 1 site observation
RECRUITING
A Study of AK112 as Consolidation Treatment for Patients With Limited Stage Small-cell Lung Cancer Who Have Not Progressed Following Concurrent Chemoradiation TherapyNCT07010263 · 2025-06-13 · 1 site observation
RECRUITING
TQC2731 Clinical Trial for the Treatment of Severe Asthma With InjectionNCT06829784 · 2025-03-21 · 1 site observation
RECRUITING
A Clinical Study on Using Multimodal Ultrasound to Assess Muscle Mass in Metabolic DiseasesNCT07836088 · 2023-07-01 · 1 site observation
RECRUITING
A Multicenter Exploratory Clinical Study of Iruplaltinib Combined With Pemetrexed as Neoadjuvant Therapy for Resectable ALK-Positive Non-Squamous Non-Small Cell Lung CancerNCT07771764 · 2026-08-01 · 1 site observation
NOT_YET_RECRUITING
Evaluation of the Clinical Trial of Inhaled TQC3721 Suspension in Patients With Moderate-to-Severe Chronic Obstructive Pulmonary DiseaseNCT07147946 · 2025-09-01 · 1 site observation
NOT_YET_RECRUITING
Safety and Efficacy of JKN2304 Inhalation Solution in Patients With Moderate to Severe COPDNCT07450482 · 2025-07-22 · 1 site observation
COMPLETED
A Clinical Trial of TQB2102 for Injection in the Treatment of HER2 Low-Expressing Recurrent/Metastatic Breast CancerNCT06561607 · 2024-10-11 · 1 site observation
ACTIVE_NOT_RECRUITING
A Study of AK104/Tislelizumab With Chemotherapy as First-line Treatment in PD-L1 TPS < 1% Non-small Cell Lung CancerNCT05990127 · 2023-11-14 · 1 site observation
NOT_YET_RECRUITING
Safety and Efficacy of YPEG-rhG-CSF in Cancer Patients Receiving ChemotherapyNCT02005458 · 2013-12-01 · 1 site observation
COMPLETED
Advertisement
Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.